Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9588099 | 0.84 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL6902398 | 0.84 | — | — | |
| SCHEMBL6909646 | 0.77 | — | — | |
| SCHEMBL6906564 | 0.75 | POLB (0.33) | POLB | |
| SCHEMBL6902154 | 0.75 | CA2 (0.34) | ALDH1A1CA2 | |
| Hydrochloric Acid SCHEMBL6906748 | 0.75 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| Hydrochloric Acid SCHEMBL6906753 | 0.75 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL12310560 | 0.68 | SMN1; SMN2 (0.65) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL6906484 | 0.68 | ALDH1A1 (0.31) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL21173499 | 0.67 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1CA2POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6730626-B2 | TRANSITION METAL DERIVATIVE CAN REACT TO FORM AN IONIC COMPLEX WITH THE ALUMINOXANE | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2004-05-04 | — | — | US | disclosed |
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | IDEMITSU KOSAN CO. LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | CCNE2, PYM1, AP1M1 | SMN1; SMN2 3341/4885ALDH1A1 2755/4885CA2 1478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.